BTC $79,713.28 -1.52%
ETH $2,454.08 -2.44%
BNB $728.91 +0.97%
XRP $1.40 -3.28%
SOL $102.40 -1.44%
TRX $0.3330 +1.46%
DOGE $0.0857 -1.86%
ADA $0.2132 -4.00%
BCH $251.55 -2.39%
LINK $11.73 -1.84%
HYPE $84.31 -2.21%
AAVE $130.01 -2.66%
SUI $0.7826 +1.23%
XLM $0.1831 -0.34%
ZEC $1,010.84 +4.26%
BTC $79,713.28 -1.52%
ETH $2,454.08 -2.44%
BNB $728.91 +0.97%
XRP $1.40 -3.28%
SOL $102.40 -1.44%
TRX $0.3330 +1.46%
DOGE $0.0857 -1.86%
ADA $0.2132 -4.00%
BCH $251.55 -2.39%
LINK $11.73 -1.84%
HYPE $84.31 -2.21%
AAVE $130.01 -2.66%
SUI $0.7826 +1.23%
XLM $0.1831 -0.34%
ZEC $1,010.84 +4.26%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.